Repression of SARS-CoV-2 Induced Hyper-inflammation by Topoisomerase I Inhibition

Aug 22, 2022
MD4 Seminar Room, Level 2

📣 #IDTRPseminar

Another interesting talk will be on Monday, 22 August 2022, at 12 noon (Singapore Time). Everyone is welcome to join this in-person seminar at our MD4, Seminar Room Level 2 on “Repression of SARS-CoV-2 Induced Hyperinflammation by Topoisomerase I Inhibition” by Dr Jessica Ho. She will share her work in evaluating the role of Topoisomerase I (TOP1) in the control of excessive inflammation during SARS-CoV-2 infection.

#TOP1 #COVID #ResearchSeminar #InfectiousDiseasesTRP #NUSMedicine

Please note that registration is onsite only and the seminar will be recorded.

Biography:
Jessica Ho received her PhD at the Rockefeller University and subsequently did her initial postdoctoral training in the IMCB in A*STAR, Singapore. She is now currently a postdoctoral fellow in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai in New York City, where she is a recipient of the Charles H. Revson Senior Fellowship in Biomedical Science. Her main research interest is in understanding epigenetic mechanisms that underlie host-pathogen interactions during viral disease.

More Seminar, Courses & Workshops

On-site

The sinonasal microbiome in health and disease

Abstract: Chronic rhinosinusitis affects 10% of the global population. It …

On-site

MERS coronavirus remains a pandemic threat?

Abstract: Zoonotic coronaviruses have caused repeated pandemics over the past …

On-site

Defining the landscape of host defences against emergent viruses

Abstract: The outcome of viral infections is significantly influenced by …